Beyond Conventional Approach: Clinical Superiority and Emerging Challenges in Psoriasis Treatment

Palak Singh, Vijendra Kumar, Prabhjot Singh Bhuie

Abstract: Background: A combination of immunological, environmental, and genetic factors can cause psoriasis, a persistent inflammatory dermatosis. It can manifest in the clinic in a variety of ways and has a significant impact on people's quality of life. Despite their widespread use, standard treatment approaches still have problems with long-term safety and efficacy, particularly in mild to severe cases. Approach: With an emphasis on contemporary therapeutic possibilities, this study extensively examines the pathophysiology, clinical features, causes, and dissemination of psoriasis. Biological agents, small-molecule medications, nano-formulations, and current medications are examples of novel approaches to illness treatment that are contrasted with conventional techniques. Traditional vs innovative treatments are compared in terms of their effectiveness, safety, and therapeutic relevance. Conclusion: New pharmaceutical therapy works better because it targets crucial inflammatory pathways that are associated to psoriasis. Even if they are expensive and hard to get, new methods work better than old treatments because they make patients more likely to follow their treatment, keep them in remission longer, and work better overall. In today's clinical practice, the newest and most popular way to treat psoriasis is using innovative therapy.

Keywords: psoriasis, Novel Treatment, Biological Agents, Nano-formulations, Conventional treatments, Innovative treatments

How to Cite?: Palak Singh, Vijendra Kumar, Prabhjot Singh Bhuie, "Beyond Conventional Approach: Clinical Superiority and Emerging Challenges in Psoriasis Treatment", Volume 15 Issue 5, May 2026, International Journal of Science and Research (IJSR), Pages: 1783-1792, https://www.ijsr.net/getabstract.php?paperid=SR26525145458, DOI: https://dx.dx.doi.org/10.21275/SR26525145458

Download Citation: APA | MLA | BibTeX | EndNote | RefMan